Skip to main content
Top
Published in: BMC Oral Health 1/2023

Open Access 01-12-2023 | Research

Oral erythroplakia and oral erythroplakia-like oral squamous cell carcinoma – what’s the difference?

Authors: Jenny Öhman, Ayelet Zlotogorski-Hurvitz, Alex Dobriyan, Shoshana Reiter, Marilena Vered, Jaana Willberg, Carlo Lajolo, Maria Siponen

Published in: BMC Oral Health | Issue 1/2023

Login to get access

Abstract

Background

Oral erythroplakia (OE) is a rare oral potentially malignant disorder, that has a high rate of malignant transformation. The definition of OE still lacks uniformity. In particular, lesions that look clinically like erythroplakias, but are histopathologically diagnosed as squamous cell carcinomas are still sometimes called erythroplakias. The purpose of this study is to present demographic and clinicopathologic features of a series of OEs and clinically oral erythroplakia -like squamous cell carcinomas (OELSCC), to study their differences and to discuss the definition of OE.

Methods

A multicenter retrospective case series of OEs and OELSCCs. Descriptive statistics were used to analyze the data.

Results

11 cases of OEs and 9 cases of OELSCCs were identified. The mean age of the OE patients was 71 years and 72.7% were female, while the mean age of the OELSCC patients was 69 years, and all were female. 9% of the OE and 22% of the OELSCC patients had smoked or were current smokers. 72.7% of the OEs and 55.5% of OELSCCs were uniformly red lesions. 63.6% of the OE and 22% of the OELSCC patients had a previous diagnosis of oral lichenoid disease (OLD). The malignant transformation rate of OE was 9% in a mean of 73 months.

Conclusions

OE and OELSCC may arise de novo or in association with OLD. Tobacco and alcohol use were not prevalent in the present cases. The clinical features of OEs and OELSCC are similar, but symptoms, uneven surface and ulceration may be more common in OELSCCs than in OEs. Clinical recognition of OE is important since it may mimic other, more innocuous red lesions of the oral mucosa. The diagnosis of OE requires biopsy and preferably an excision. Clarification of the definition of OE would aid in clinical diagnostics.
Appendix
Available only for authorised users
Literature
1.
go back to reference Warnakulasuriya S, Kujan O, Aguirre-Urizar JM, Bagan JV, González-Moles MÁ, Kerr AR, et al. Oral potentially malignant disorders: a consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer. Oral Dis. 2021;27(8):1862–80. Warnakulasuriya S, Kujan O, Aguirre-Urizar JM, Bagan JV, González-Moles MÁ, Kerr AR, et al. Oral potentially malignant disorders: a consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer. Oral Dis. 2021;27(8):1862–80.
2.
go back to reference Lorenzo-Pouso AI, Lafuente-Ibáñez de Mendoza I, Pérez-Sayáns M, Pérez-Jardón A, Chamorro-Petronacci CM, Blanco-Carrión A, et al. Critical update, systematic review, and meta-analysis of oral erythroplakia as an oral potentially malignant disorder. J Oral Pathol Med. 2022;51(7):585–93.CrossRef Lorenzo-Pouso AI, Lafuente-Ibáñez de Mendoza I, Pérez-Sayáns M, Pérez-Jardón A, Chamorro-Petronacci CM, Blanco-Carrión A, et al. Critical update, systematic review, and meta-analysis of oral erythroplakia as an oral potentially malignant disorder. J Oral Pathol Med. 2022;51(7):585–93.CrossRef
3.
go back to reference Iocca O, Sollecito TP, Alawi F, Weinstein GS, Newman JG, Virgilio AD, et al. Potentially malignant disorders of the oral cavity and oral dysplasia: a systematic review and meta-analysis of malignant transformation rate by subtype. Head Neck. 2020;42(3):539–55.PubMedCrossRef Iocca O, Sollecito TP, Alawi F, Weinstein GS, Newman JG, Virgilio AD, et al. Potentially malignant disorders of the oral cavity and oral dysplasia: a systematic review and meta-analysis of malignant transformation rate by subtype. Head Neck. 2020;42(3):539–55.PubMedCrossRef
4.
go back to reference Villa A, Villa C, Abati S. Oral cancer and oral erythroplakia: an update and implication for clinicians. Aust Dent J. 2011;56(3):253–6.PubMedCrossRef Villa A, Villa C, Abati S. Oral cancer and oral erythroplakia: an update and implication for clinicians. Aust Dent J. 2011;56(3):253–6.PubMedCrossRef
5.
go back to reference Mello FW, Miguel AFP, Dutra KL, Porporatti AL, Warnakulasuriya S, Guerra ENS, et al. Prevalence of oral potentially malignant disorders: a systematic review and meta-analysis. J Oral Pathol Med. 2018;47(7):633–40.CrossRef Mello FW, Miguel AFP, Dutra KL, Porporatti AL, Warnakulasuriya S, Guerra ENS, et al. Prevalence of oral potentially malignant disorders: a systematic review and meta-analysis. J Oral Pathol Med. 2018;47(7):633–40.CrossRef
7.
8.
go back to reference Warnakulasuriya S. Clinical features and presentation of oral potentially malignant disorders. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125(6):582–90. Warnakulasuriya S. Clinical features and presentation of oral potentially malignant disorders. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125(6):582–90.
9.
go back to reference Hashibe M, Mathew B, Kuruvilla B, Thomas G, Sankaranarayanan R, Parkin DM, et al. Chewing tobacco, alcohol, and the risk of erythroplakia. Cancer Epidemiol Biomarkers Prev. 2000;9(7):639–45. Hashibe M, Mathew B, Kuruvilla B, Thomas G, Sankaranarayanan R, Parkin DM, et al. Chewing tobacco, alcohol, and the risk of erythroplakia. Cancer Epidemiol Biomarkers Prev. 2000;9(7):639–45.
10.
go back to reference Jacob BJ, Straif K, Thomas G, Ramadas K, Mathew B, Zhang ZF, et al. Betel quid without tobacco as a risk factor for oral precancers. Oral Oncol. 2004;40(7):697–704.PubMedCrossRef Jacob BJ, Straif K, Thomas G, Ramadas K, Mathew B, Zhang ZF, et al. Betel quid without tobacco as a risk factor for oral precancers. Oral Oncol. 2004;40(7):697–704.PubMedCrossRef
12.
go back to reference Queyrat L. Érythroplasie du gland. Bull Soc Fr Dermatol Syphiligr 1911;22:378–82. Queyrat L. Érythroplasie du gland. Bull Soc Fr Dermatol Syphiligr 1911;22:378–82.
13.
go back to reference Shear M. Erythroplakia of the mouth. Int Dent J. 1972;22(4):460–73.PubMed Shear M. Erythroplakia of the mouth. Int Dent J. 1972;22(4):460–73.PubMed
14.
go back to reference Shedd DP, Hukill PB, Kligerman MM, Gowen GF. A clinicopathologic study of oral carcinoma in situ. Am J Surg. 1963;106:791–6.PubMedCrossRef Shedd DP, Hukill PB, Kligerman MM, Gowen GF. A clinicopathologic study of oral carcinoma in situ. Am J Surg. 1963;106:791–6.PubMedCrossRef
15.
go back to reference Sachs W, Sachs PM. Erythroplasia of Queyrat; report of ten cases. Arch Derm Syphilol. 1948;58(2):184–90.PubMedCrossRef Sachs W, Sachs PM. Erythroplasia of Queyrat; report of ten cases. Arch Derm Syphilol. 1948;58(2):184–90.PubMedCrossRef
16.
go back to reference Mashberg A, Morrissey JB, Garfinkel L. A study of the appearance of early asymptomatic oral squamous cell carcinoma. Cancer. 1973;32(6):1436–45.PubMedCrossRef Mashberg A, Morrissey JB, Garfinkel L. A study of the appearance of early asymptomatic oral squamous cell carcinoma. Cancer. 1973;32(6):1436–45.PubMedCrossRef
17.
go back to reference Mashberg A, Feldman LJ. Clinical criteria for identifying early oral and oropharyngeal carcinoma: erythroplasia revisited. Am J Surg. 1988;156(4):273–5.PubMedCrossRef Mashberg A, Feldman LJ. Clinical criteria for identifying early oral and oropharyngeal carcinoma: erythroplasia revisited. Am J Surg. 1988;156(4):273–5.PubMedCrossRef
18.
go back to reference Speight PM, Khurram SA, Kujan O. Oral potentially malignant disorders: risk of progression to malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125(6):612–27. Speight PM, Khurram SA, Kujan O. Oral potentially malignant disorders: risk of progression to malignancy. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125(6):612–27.
19.
go back to reference van der Waal I. Historical perspective and nomenclature of potentially malignant or potentially premalignant oral epithelial lesions with emphasis on leukoplakia-some suggestions for modifications. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125(6):577–81. van der Waal I. Historical perspective and nomenclature of potentially malignant or potentially premalignant oral epithelial lesions with emphasis on leukoplakia-some suggestions for modifications. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018;125(6):577–81.
20.
go back to reference Diz P, Gorsky M, Johnson NW, Kragelund C, Manfredi M, Odell E et al. Oral leukoplakia and erythroplakia: a protocol for diagnosis and management. Diz P, Gorsky M, Johnson NW, Kragelund C, Manfredi M, Odell E et al. Oral leukoplakia and erythroplakia: a protocol for diagnosis and management.
21.
go back to reference Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007;36(10):575–80.CrossRef Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med. 2007;36(10):575–80.CrossRef
22.
go back to reference Odell EW. Cawson’s essentials of oral pathology and oral medicine. 9th ed. Elsevier; 2017. Odell EW. Cawson’s essentials of oral pathology and oral medicine. 9th ed. Elsevier; 2017.
24.
go back to reference El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO Classification of Head and Neck Tumours. 4th ed. Lyon: International Agency for Research on Cancer; 2017. El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ, editors. WHO Classification of Head and Neck Tumours. 4th ed. Lyon: International Agency for Research on Cancer; 2017.
25.
go back to reference Lapthanasupkul P, Poomsawat S, Punyasingh J. A clinicopathologic study of oral leukoplakia and erythroplakia in a Thai population. Quintessence Int. 2007;38(8):e448–55. Lapthanasupkul P, Poomsawat S, Punyasingh J. A clinicopathologic study of oral leukoplakia and erythroplakia in a Thai population. Quintessence Int. 2007;38(8):e448–55.
26.
go back to reference Quieroz SIML, de Medeiros AMC, da Silva JSP, da Silveira ÉJD. Clinical and histopathological evaluation and habits associated with the onset of oral leukoplakia and erythroplakia. J Bras Patol Med Lab. 2014;50(2):144–9. Quieroz SIML, de Medeiros AMC, da Silva JSP, da Silveira ÉJD. Clinical and histopathological evaluation and habits associated with the onset of oral leukoplakia and erythroplakia. J Bras Patol Med Lab. 2014;50(2):144–9.
27.
go back to reference Yang SW, Lee YS, Chang LC, Hsieh TY, Chen TA. Outcome of excision of oral erythroplakia. Br J Oral Maxillofac Surg. 2015;53(2):142–7.PubMedCrossRef Yang SW, Lee YS, Chang LC, Hsieh TY, Chen TA. Outcome of excision of oral erythroplakia. Br J Oral Maxillofac Surg. 2015;53(2):142–7.PubMedCrossRef
28.
go back to reference Holmstrup P, Pindborg JJ. Erythroplakic lesions in relation to oral lichen planus. Acta Derm Venereol Suppl (Stockh). 1979;59(85):77–84. Holmstrup P, Pindborg JJ. Erythroplakic lesions in relation to oral lichen planus. Acta Derm Venereol Suppl (Stockh). 1979;59(85):77–84.
29.
30.
go back to reference Pindborg JJ, Reichart PA, Smith CJ. van der WaaI l. Histological typing of precancer and cancer of the oral mucosa. 2nd ed. Berlin, Heidelberg: Springer-Verlag; 1997.CrossRef Pindborg JJ, Reichart PA, Smith CJ. van der WaaI l. Histological typing of precancer and cancer of the oral mucosa. 2nd ed. Berlin, Heidelberg: Springer-Verlag; 1997.CrossRef
31.
go back to reference Amagasa T, Yokoo E, Sato K, Tanaka N, Shioda S, Takagi M. A study of the clinical characteristics and treatment of oral carcinoma in situ. Oral Surg Oral Med Oral Pathol. 1985;60(1):50–5. Amagasa T, Yokoo E, Sato K, Tanaka N, Shioda S, Takagi M. A study of the clinical characteristics and treatment of oral carcinoma in situ. Oral Surg Oral Med Oral Pathol. 1985;60(1):50–5.
32.
go back to reference Ferrer AD, Granados FA, Jimenez JS, Manegold MP, Ferrer RD, Salvatierra J. Erythroplakia of the oral cavity. An aggressive premalignant lesion: presentation of six case reports. Med Oral. 2000;5(5):324–30. Ferrer AD, Granados FA, Jimenez JS, Manegold MP, Ferrer RD, Salvatierra J. Erythroplakia of the oral cavity. An aggressive premalignant lesion: presentation of six case reports. Med Oral. 2000;5(5):324–30.
33.
go back to reference Hosni ES, Salum FG, Cherubini K, Yurgel LS, Figueiredo MA. Oral erythroplakia and speckled leukoplakia: retrospective analysis of 13 cases. Braz J Otorhinolaryngol. 2009;75(2):295–9.PubMedCrossRef Hosni ES, Salum FG, Cherubini K, Yurgel LS, Figueiredo MA. Oral erythroplakia and speckled leukoplakia: retrospective analysis of 13 cases. Braz J Otorhinolaryngol. 2009;75(2):295–9.PubMedCrossRef
34.
go back to reference de Azevedo AB, Dos Santos TCRB, Lopes MA, Pires FR. Oral leukoplakia, leukoerythroplakia, erythroplakia and actinic cheilitis: analysis of 953 patients focusing on oral epithelial dysplasia. J Oral Pathol Med. 2021;50(8):829–40.PubMedCrossRef de Azevedo AB, Dos Santos TCRB, Lopes MA, Pires FR. Oral leukoplakia, leukoerythroplakia, erythroplakia and actinic cheilitis: analysis of 953 patients focusing on oral epithelial dysplasia. J Oral Pathol Med. 2021;50(8):829–40.PubMedCrossRef
35.
go back to reference Holmstrup P, Vedtofte P, Reibel J, Stoltze K. Long-term treatment outcome of oral premalignant lesions. Oral Oncol. 2006;42(5):461–74.PubMedCrossRef Holmstrup P, Vedtofte P, Reibel J, Stoltze K. Long-term treatment outcome of oral premalignant lesions. Oral Oncol. 2006;42(5):461–74.PubMedCrossRef
36.
go back to reference Holmstrup P, Vedtofte P, Reibel J, Stoltze K. Oral premalignant lesions: is a biopsy reliable? J Oral Pathol Med. 2007;36(5):262–6.PubMedCrossRef Holmstrup P, Vedtofte P, Reibel J, Stoltze K. Oral premalignant lesions: is a biopsy reliable? J Oral Pathol Med. 2007;36(5):262–6.PubMedCrossRef
37.
go back to reference Gilvetti C, Soneji C, Bisase B, Barrett AW. Recurrence and malignant transformation rates of high grade oral epithelial dysplasia over a 10 year follow up period and the influence of surgical intervention, size of excision biopsy and marginal clearance in a UK regional maxillofacial surgery unit. Oral Oncol. 2021;121:105462.PubMedCrossRef Gilvetti C, Soneji C, Bisase B, Barrett AW. Recurrence and malignant transformation rates of high grade oral epithelial dysplasia over a 10 year follow up period and the influence of surgical intervention, size of excision biopsy and marginal clearance in a UK regional maxillofacial surgery unit. Oral Oncol. 2021;121:105462.PubMedCrossRef
38.
go back to reference Walsh T, Macey R, Kerr AR, Lingen MW, Ogden GR, Warnakulasuriya S. Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions. Cochrane Database Syst Rev. 2021;7(7):CD010276. Walsh T, Macey R, Kerr AR, Lingen MW, Ogden GR, Warnakulasuriya S. Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions. Cochrane Database Syst Rev. 2021;7(7):CD010276.
39.
go back to reference Lingen MW, Tampi MP, Urquhart O, Abt E, Agrawal N, Chaturvedi AK, et al. Adjuncts for the evaluation of potentially malignant disorders in the oral cavity. J Am Dent Assoc. 2017;148(11):797–813.e52.CrossRef Lingen MW, Tampi MP, Urquhart O, Abt E, Agrawal N, Chaturvedi AK, et al. Adjuncts for the evaluation of potentially malignant disorders in the oral cavity. J Am Dent Assoc. 2017;148(11):797–813.e52.CrossRef
40.
go back to reference Kerr AR, Lodi G. Management of oral potentially malignant disorders. Oral Dis. 2021;27(8):2008–25.PubMedCrossRef Kerr AR, Lodi G. Management of oral potentially malignant disorders. Oral Dis. 2021;27(8):2008–25.PubMedCrossRef
41.
go back to reference Warnakulasuriya S. Oral potentially malignant disorders: a comprehensive review on clinical aspects and management. Oral Oncol. 2020;102:104550.PubMedCrossRef Warnakulasuriya S. Oral potentially malignant disorders: a comprehensive review on clinical aspects and management. Oral Oncol. 2020;102:104550.PubMedCrossRef
42.
go back to reference Vedtofte P, Holmstrup P, Hjørting-Hansen E, Pindborg JJ. Surgical treatment of premalignant lesions of the oral mucosa. Int J Oral Maxillofac Surg. 1987;16(6):656–64.PubMedCrossRef Vedtofte P, Holmstrup P, Hjørting-Hansen E, Pindborg JJ. Surgical treatment of premalignant lesions of the oral mucosa. Int J Oral Maxillofac Surg. 1987;16(6):656–64.PubMedCrossRef
Metadata
Title
Oral erythroplakia and oral erythroplakia-like oral squamous cell carcinoma – what’s the difference?
Authors
Jenny Öhman
Ayelet Zlotogorski-Hurvitz
Alex Dobriyan
Shoshana Reiter
Marilena Vered
Jaana Willberg
Carlo Lajolo
Maria Siponen
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Oral Health / Issue 1/2023
Electronic ISSN: 1472-6831
DOI
https://doi.org/10.1186/s12903-023-03619-2

Other articles of this Issue 1/2023

BMC Oral Health 1/2023 Go to the issue